| Financial Year |
March 31 2023 |
| Monetary Funds |
1,659,750,736.65 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
866,054,598.68 |
| Advances to Suppliers |
67,609,881.04 |
| Other Receivables |
39,103,367.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,655,592,449.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,385,412.85 |
| Total Current Assets |
4,344,442,459.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
437,198,236.33 |
| Investment Properties |
-- |
| Fixed Assetes |
3,941,967,956.16 |
| Under-construction Projects |
633,795,831.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
486,192,140.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
129,021,050.08 |
| Deferred Income Tax Assets |
19,668,958.74 |
| Other Non-Current Assets |
143,740,389.89 |
| Sub-Total of Non-Current Assets |
5,817,664,546.83 |
| Total Assets |
10,162,107,006.19 |
| Short-Term Loans |
2,130,957,121.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
144,086,558.25 |
| Accounts Payable |
1,116,967,594.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,622,082.79 |
| Taxes Payable |
4,726,498.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,452,597.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
424,909,432.80 |
| Other Current Liabilities |
2,219,955.16 |
| Sub-Total of Current Liabilities |
3,925,210,399.31 |
| Long-term Loans |
848,704,488.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
24,900,696.56 |
| Deferred Income Tax Liabilities |
6,686,477.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
916,878,718.20 |
| Total Liabilities |
4,842,089,117.51 |
| Paid-In Capital(Or Share Stock) |
1,581,123,135.00 |
| Capital Surplus |
2,702,385,638.43 |
| Surplus Reserve |
161,740,533.32 |
| LESS:Treasury Stock |
9,894,080.00 |
| Undistributed Profits |
950,354,569.08 |
| Minority Stockholder's Interest |
7,361,073.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,312,656,815.26 |
| Owner's Equity（Stockholder's Equity） |
5,320,017,888.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,162,107,006.19 |
